These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 11344644)
1. [Lipids and acute coronary syndromes]. Stejfa M Vnitr Lek; 2000 Sep; 46(9):520-5. PubMed ID: 11344644 [TBL] [Abstract][Full Text] [Related]
2. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly. Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195 [TBL] [Abstract][Full Text] [Related]
3. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related]
4. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient. Ong HT QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatment of type 2 diabetic dyslipidemia. Moon YS; Kashyap ML Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439 [TBL] [Abstract][Full Text] [Related]
6. Protecting the heart: a practical review of the statin studies. Ong HT MedGenMed; 2002 Dec; 4(4):1. PubMed ID: 12817199 [TBL] [Abstract][Full Text] [Related]
7. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease. Staels B; Maes M; Zambon A Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776 [TBL] [Abstract][Full Text] [Related]
9. Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents. Dupuy AM; Carrière I; Scali J; Cristol JP; Ritchie K; Dartigues JF; Gambert P; Ancelin ML Climacteric; 2008 Feb; 11(1):74-83. PubMed ID: 18202967 [TBL] [Abstract][Full Text] [Related]
10. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies. Gresser U; Gathof BS Eur J Med Res; 2004 Jan; 9(1):1-17. PubMed ID: 14766335 [TBL] [Abstract][Full Text] [Related]
11. Achieving vascular risk factor targets: a survey of a London general practice. Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M Angiology; 2008; 59(1):36-46. PubMed ID: 18319220 [TBL] [Abstract][Full Text] [Related]
12. Lipids in type 2 diabetes. Laakso M Semin Vasc Med; 2002 Feb; 2(1):59-66. PubMed ID: 16222596 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial. Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317 [TBL] [Abstract][Full Text] [Related]
14. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276 [TBL] [Abstract][Full Text] [Related]
15. Reduction of myocardial ischemia with simvastatin in addition to conventional treatment in patients with chronic coronary artery disease. Verri V; Cunha AB; Tessarolo LE; Carneiro RC; Romêo Filho LJ Rev Port Cardiol; 2004 Sep; 23(9):1089-105. PubMed ID: 15587571 [TBL] [Abstract][Full Text] [Related]
16. Do Singapore patients require lower doses of statins? The SGH Lipid Clinic experience. Tan CE; Loh LM; Tai ES Singapore Med J; 2003 Dec; 44(12):635-8. PubMed ID: 14770258 [TBL] [Abstract][Full Text] [Related]
17. [Lipid-lowering therapy in patients with type-2 diabetes mellitus]. Pados G; Audikovszky M Orv Hetil; 2003 Mar; 144(12):557-61. PubMed ID: 12723526 [TBL] [Abstract][Full Text] [Related]